These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23339165)
1. Sex-specific mTOR signaling determines sexual dimorphism in myocardial adaptation in normotensive DOCA-salt model. Gürgen D; Kusch A; Klewitz R; Hoff U; Catar R; Hegner B; Kintscher U; Luft FC; Dragun D Hypertension; 2013 Mar; 61(3):730-6. PubMed ID: 23339165 [TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-beta signals left ventricular hypertrophy sex differences in normotensive deoxycorticosterone acetate-salt mice. Gürgen D; Hegner B; Kusch A; Catar R; Chaykovska L; Hoff U; Gross V; Slowinski T; da Costa Goncalves AC; Kintscher U; Gustafsson JÅ; Luft FC; Dragun D Hypertension; 2011 Mar; 57(3):648-54. PubMed ID: 21300662 [TBL] [Abstract][Full Text] [Related]
3. 17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling. Kusch A; Schmidt M; Gürgen D; Postpieszala D; Catar R; Hegner B; Davidson MM; Mahmoodzadeh S; Dragun D PLoS One; 2015; 10(4):e0123385. PubMed ID: 25880554 [TBL] [Abstract][Full Text] [Related]
4. Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism. Karatas A; Hegner B; de Windt LJ; Luft FC; Schubert C; Gross V; Akashi YJ; Gürgen D; Kintscher U; da Costa Goncalves AC; Regitz-Zagrosek V; Dragun D Hypertension; 2008 Apr; 51(4):1177-83. PubMed ID: 18259006 [TBL] [Abstract][Full Text] [Related]
5. Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated mice. Wang Q; Domenighetti AA; Schäfer SC; Weber J; Simon A; Maillard MP; Pedrazzini T; Chen J; Lehr HA; Burnier M Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(9):R1025-33. PubMed ID: 22403797 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in exercise-induced physiological myocardial hypertrophy are modulated by oestrogen receptor beta. Dworatzek E; Mahmoodzadeh S; Schubert C; Westphal C; Leber J; Kusch A; Kararigas G; Fliegner D; Moulin M; Ventura-Clapier R; Gustafsson JA; Davidson MM; Dragun D; Regitz-Zagrosek V Cardiovasc Res; 2014 Jun; 102(3):418-28. PubMed ID: 24654233 [TBL] [Abstract][Full Text] [Related]
7. Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension. Sun Y; Carretero OA; Xu J; Rhaleb NE; Wang F; Lin C; Yang JJ; Pagano PJ; Yang XP Hypertension; 2005 Dec; 46(6):1355-61. PubMed ID: 16286571 [TBL] [Abstract][Full Text] [Related]
8. Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy. Shende P; Xu L; Morandi C; Pentassuglia L; Heim P; Lebboukh S; Berthonneche C; Pedrazzini T; Kaufmann BA; Hall MN; Rüegg MA; Brink M Cardiovasc Res; 2016 Jan; 109(1):103-14. PubMed ID: 26598511 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological Inhibition of Mammalian Target of Rapamycin Attenuates Deoxycorticosterone Acetate Salt-Induced Hypertension and Related Pathophysiology: Regulation of Oxidative Stress, Inflammation, and Cardiovascular Hypertrophy in Male Rats. Temiz-Resitoglu M; Guden DS; Senol SP; Vezir O; Sucu N; Kibar D; Yılmaz SN; Tunctan B; Malik KU; Sahan-Firat S J Cardiovasc Pharmacol; 2022 Mar; 79(3):355-367. PubMed ID: 34840266 [TBL] [Abstract][Full Text] [Related]
10. Induction of hypertension and cardiac hypertrophy in guinea pig by DOCA salt. Tiritilli A; Ruff F Methods Find Exp Clin Pharmacol; 1994; 16(6):391-6. PubMed ID: 7837830 [TBL] [Abstract][Full Text] [Related]
11. Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice. Baar EL; Carbajal KA; Ong IM; Lamming DW Aging Cell; 2016 Feb; 15(1):155-66. PubMed ID: 26695882 [TBL] [Abstract][Full Text] [Related]
12. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension. Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138 [TBL] [Abstract][Full Text] [Related]
14. Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice. Cao HJ; Fang J; Zhang YL; Zou LX; Han X; Yang J; Yan X; Li PB; Wang HX; Guo SB; Li HH J Mol Cell Cardiol; 2019 Dec; 137():34-45. PubMed ID: 31629736 [TBL] [Abstract][Full Text] [Related]
15. Cardiac Ablation of SOCS3 Aggravates DOCA-Salt-Induced Hypertrophic Remodeling by Activation of Gp130-Dependent Signaling in Mice. Liu S; Liu LX; Zhang YL; Lai S; Xie YP; Li NN; Wang HX; Xia YL; Liu Y; Li HH Cell Physiol Biochem; 2018; 47(1):140-150. PubMed ID: 29763909 [TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid signaling in transition to heart failure with normal ejection fraction. Shapiro BP; Owan TE; Mohammed S; Kruger M; Linke WA; Burnett JC; Redfield MM Hypertension; 2008 Feb; 51(2):289-95. PubMed ID: 18086943 [TBL] [Abstract][Full Text] [Related]
17. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice. Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic Suppression of mTOR (Mammalian Target of Rapamycin) Signaling Prevents and Reverses Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats. Kumar V; Evans LC; Kurth T; Yang C; Wollner C; Nasci V; Zheleznova NN; Bukowy J; Dayton A; Cowley AW Hypertension; 2019 Mar; 73(3):630-639. PubMed ID: 30595123 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats. Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735 [TBL] [Abstract][Full Text] [Related]
20. mTOR inhibitor improves testosterone-induced myocardial hypertrophy in hypertensive rats. Chen J; Yu J; Yuan R; Li N; Li C; Zhang X J Endocrinol; 2022 Jan; 252(3):179-193. PubMed ID: 34874016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]